Airway and Lung Infection
An Introduction to Airway and Lung Infection
The field of airway and lung infection is topical in the wake of the COVID-19 pandemic; SARS-CoV-2 is one of several novel respiratory viruses to emerge in the 21st century. Viruses and bacteria can cause a range of respiratory diseases, including acute bronchitis, the common cold, influenza, respiratory distress syndromes, pertussis, pneumonia and tuberculosis. Symptoms of viral infections may range from being very mild to a severe respiratory illness, and therefore prompt and reliable diagnosis is essential. Antibiotic resistance remains the major challenge in bacterial infection. Emerging approaches include cell-based therapies involving mesenchymal stem cells in the treatment of respiratory infections. However, the multiple challenges involved in developing curative therapies for infections highlight the importance of prevention, and vaccine research is essential.
Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Airway and Lung Infection Content
Recent Advances in Primary Ciliary Dyskinesia: From Diagnosis to Treatment
touchREVIEWS in Respiratory & Pulmonary Diseases. 2021;6(1):14–20
Primary ciliary dyskinesia (PCD), previously known as immotile cilia syndrome, is a rare genetic disease characterized by abnormal ciliary function due to defects in the structure and/or function of motile cilia, leading to recurrent and chronic infections of the upper and lower airways as a result of impaired mucociliary clearance.1 PCD is predominantly inherited in […]
Proton Pump Inhibitors and Risk of Infection: Is Suppression of Immune Defence Molecules to Blame?
touchREVIEWS in Respiratory & Pulmonary Diseases. 2021;6(1):3–4
Proton pump inhibitors (PPIs) are a class of antacid drugs that are available by prescription and over-the-counter to treat gastro-oesophageal reflux disease in patients with a number of comorbidities, including chronic respiratory diseases, such as asthma, pulmonary arterial hypertension, chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.1 Although they are generally regarded as safe and effective […]
Non-tuberculous Mycobacteria Infection: A Neglected Disease in Bangladesh
touchREVIEWS in Respiratory & Pulmonary Diseases. 2021;6(1):10–3
Despite huge strides in the fight against TB, the WHO’s Global Tuberculosis Report 2019 ranked Bangladesh sixth among the countries with the highest number of TB cases (4% of the global total), and seventh among the top 10 countries with the widest gap between notified and incident TB cases.1 Funding for TB programmes remains challenging and an obstacle […]
June Kehlet Marthin, ERS 2021: The International BEAT-PCD Consensus Statement
We were delighted to talk with Dr June Kehlet Marthin around the international consensus statement for infection prevention and control in patients with primary ciliary dyskinesia. The abstract ‘International BEAT-PCD Consensus Statement for infection prevention and control in Primary Ciliary Dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives.’ was presented at ERS […]
8th International Workshop on Lung Health—FUHeL Mentoring Programme
The Future Leaders Mentoring Programme has become one of the most important activities at the annual International Workshop on Lung Health (IWHL) meeting. In this video, we look back at testimonials from previous participants, as the IWHL launches its 2021 edition entitled: The FUHeL (Future Health Leader of Lungs) Mentoring Programme. Further information about this […]
Updates on nontuberculous mycobacteria
Watch leading experts discuss the need for greater awareness and understanding of NTM-LD and a multidisciplinary approach to it’s managment may help improve outcomes for patients
8th International Workshop on Lung Health – Prof. Francesco Blasi
Professor Francesco Blasi, President of the 8th International Workshop on Lung Health, discusses the theme of the next Lung Health Congress, treatable and targetable traits in the management of respiratory disorders. The 8th International Workshop on Lung Health will be held in The Hague, Netherlands 14-16 January 2021. This video was produced by the International […]
COVID-19 Era With or Without Lockdown – Tuberculosis Control Measures Through Tuberculosis Program Clinics Must Go On
Dr Juzar Ali, Professor of Medicine, is an academic clinician/clinical educator/clinical researcher within the section of pulmonary critical care at Louisiana State University Health Sciences Center (LSUHSC) New Orleans. He has worked nationally and internationally in the field of tuberculosis, and at the LSUHSC has developed programs that contribute to the education of medical students, […]
Respiratory Syncytial Virus – the Quest for Effective Prevention
Respiratory syncytial virus (RSV) is an RNA virus that causes lung and respiratory tract infections. It is a leading cause of morbidity and mortality, and is the second largest cause of death in children under 1 year of age. In 2017, it was estimated that RSV causes around 33.1 million episodes, 3.2 million hospital admissions, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!